Stifel Financial Corp lowered its stake in shares of Genpact Limited (NYSE:G) by 2.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 178,397 shares of the business services provider’s stock after selling 5,120 shares during the quarter. Stifel Financial Corp owned about 0.09% of Genpact Limited worth $4,953,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently modified their holdings of G. First Trust Advisors LP bought a new stake in Genpact Limited during the first quarter valued at about $885,000. BNP Paribas Arbitrage SA boosted its position in Genpact Limited by 85.3% during the first quarter. BNP Paribas Arbitrage SA now owns 5,220 shares of the business services provider’s stock valued at $129,000 after purchasing an additional 2,403 shares in the last quarter. Comerica Bank boosted its position in Genpact Limited by 3.6% during the first quarter. Comerica Bank now owns 61,272 shares of the business services provider’s stock valued at $1,506,000 after purchasing an additional 2,106 shares in the last quarter. UBS Asset Management Americas Inc. boosted its position in Genpact Limited by 12.8% during the first quarter. UBS Asset Management Americas Inc. now owns 34,667 shares of the business services provider’s stock valued at $858,000 after purchasing an additional 3,933 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its position in Genpact Limited by 85.5% during the first quarter. Ameriprise Financial Inc. now owns 29,289 shares of the business services provider’s stock valued at $725,000 after purchasing an additional 13,502 shares in the last quarter. 92.16% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This news story was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/08/stifel-financial-corp-sells-5120-shares-of-genpact-limited-g.html.

In other news, major shareholder Bain Capital Investors Llc sold 8,498,874 shares of the company’s stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $28.72, for a total transaction of $244,087,661.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Amit Chandra sold 275,508 shares of the company’s stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $28.72, for a total value of $7,912,589.76. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 10,358,442 shares of company stock valued at $297,475,276. Insiders own 1.55% of the company’s stock.

A number of equities research analysts recently weighed in on the company. Zacks Investment Research downgraded Genpact Limited from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Deutsche Bank AG raised their price objective on Genpact Limited from $26.00 to $28.00 and gave the company a “hold” rating in a research report on Thursday, August 3rd. Cowen and Company reaffirmed an “outperform” rating and set a $33.00 price objective (up previously from $30.00) on shares of Genpact Limited in a research report on Thursday, August 3rd. Cantor Fitzgerald reaffirmed a “buy” rating and set a $32.00 price objective on shares of Genpact Limited in a research report on Wednesday, September 13th. Finally, BMO Capital Markets reaffirmed a “hold” rating on shares of Genpact Limited in a research report on Friday. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $31.86.

Shares of Genpact Limited (NYSE G) opened at 29.14 on Friday. Genpact Limited has a one year low of $22.62 and a one year high of $31.93. The firm has a 50-day moving average price of $28.44 and a 200 day moving average price of $27.09. The firm has a market cap of $5.62 billion, a P/E ratio of 22.01 and a beta of 0.53.

Genpact Limited (NYSE:G) last released its quarterly earnings data on Wednesday, August 2nd. The business services provider reported $0.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.31 by $0.10. The business had revenue of $670.70 million during the quarter, compared to analysts’ expectations of $642.68 million. Genpact Limited had a return on equity of 23.33% and a net margin of 10.22%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.36 EPS. On average, analysts forecast that Genpact Limited will post $1.56 earnings per share for the current fiscal year.

The firm also recently disclosed a special dividend, which was paid on Thursday, September 21st. Stockholders of record on Friday, September 8th were given a dividend of $0.06 per share. The ex-dividend date was Thursday, September 7th. This represents a dividend yield of 0.84%. Genpact Limited’s dividend payout ratio is currently 18.05%.

Genpact Limited Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G).

Institutional Ownership by Quarter for Genpact Limited (NYSE:G)

Receive News & Stock Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related stocks with our FREE daily email newsletter.